1. 2020
  2. The impact of optimized mRNA on cancer vaccination

    De Mey, W., Lecocq, Q., Autaers, D., Breckpot, K., Thielemans, K. & Franceschini, L., 7 Feb 2020, (Unpublished).

    Research output: Unpublished contribution to conferencePoster

  3. 2019
  4. Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

    iHIVARNA consortium, de Jong, W., Aerts, J., Allard, S., Brander, C., Buyze, J., Florence, E., van Gorp, E., Vanham, G., Leal, L., Mothe, B., Thielemans, K., Plana, M., Garcia, F. & Gruters, R., 13 Dec 2019, In : Trials. 20, 1, 721.

    Research output: Contribution to journalComment/debate

  5. Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix

    Jong, W. D., Leal, L., Buyze, J., Pannus, P., Guardo, A., Salgado, M., Mothe, B., Molto, J., Moron-Lopez, S., Gálvez, C., Florence, E., Vanham, G., Gorp, E. V., Brander, C., Allard, S., Thielemans, K., Martinez-Picado, J., Plana, M., García, F. & Gruters, R. A., 6 Dec 2019, In : Vaccines. 7, 4, 209.

    Research output: Contribution to journalArticle

  6. Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice

    Joe, P. T., Christopoulou, I., van Hoecke, L., Schepens, B., Ysenbaert, T., Heirman, C., Thielemans, K., Saelens, X. & Aerts, J. L., 25 Jul 2019, In : Journal of Translational Medicine. 17, 1, 14 p., 242.

    Research output: Contribution to journalArticle

  7. iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

    iHIVARNA consortium, de Jong, W., Aerts, J., Allard, S., Brander, C., Buyze, J., Florence, E., van Gorp, E., Vanham, G., Leal, L., Mothe, B., Thielemans, K., Plana, M., Garcia, F. & Gruters, R., 17 Jun 2019, In : Trials. 20, 1, 10 p., 361.

    Research output: Contribution to journalArticle

  8. 2018
  9. Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend

    Locy, H., de Mey, S., De Mey, W., De Ridder, M., Thielemans, K. & Maenhout, S., 11 Dec 2018, In : Frontiers in Immunology. 9, 18 p., 2909.

    Research output: Contribution to journalScientific review

  10. Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection

    iHIVARNA consortium, Leal, L., Guardo, A. C., Morón-López, S., Salgado, M., Mothe, B., Heirman, C., Pannus, P., Vanham, G., van den Ham, H. J., Gruters, R., Andeweg, A., Van Meirvenne, S., Pich, J., Arnaiz, J. A., Gatell, J. M., Brander, C., Thielemans, K., Martínez-Picado, J., Plana, M. & 1 others, García, F., 13 Nov 2018, In : AIDS. 32, 17, p. 2533-2545 13 p.

    Research output: Contribution to journalArticle

  11. Dendritic Cells: The Tools for Cancer Treatment

    Locy, H., Melhaoui, S., Maenhout, S. & Thielemans, K., 7 Nov 2018, Dendritic cells. Chapoval, S. P. (ed.). p. 101-128

    Research output: Chapter in Book/Report/Conference proceedingChapter

Previous 1 2 3 4 5 6 7 8 ...44 Next

ID: 180809